Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.

Conclusions: In DAPA-HF, outpatient episodes of HF worsening were common, of prognostic importance and reduced by dapagliflozin. Clinical Trial Registration: URL: https://clinicaltrials.gov Unique Identifier: NCT03036124. PMID: 32883108 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32883108?dopt=Abstract

Source: Circulation - September 3, 2020 Category: Cardiology Authors: Docherty KF, Jhund PS, Anand I, Bengtsson O, Böhm M, de Boer RA, DeMets DL, Desai AS, Drozdz J, Howlett J, Inzucchi SE, Johanson P, Katova T, Køber L, Kosiborod MN, Langkilde AM, Lindholm D, Martinez FA, Merkely B, Nicolau JC, O'Meara E, Ponikowski P, S Tags: Circulation Source Type: research